RNA, U12 small nuclear 2, pseudogene (RNU12-2P)

RNA, U12 small nuclear 2, pseudogene (RNU12-2P) is cataloged as a pseudogene, meaning it resembles the functional RNU12 gene but does not produce an active snRNA product or have a clearly defined biological function[1][5][6]. Unlike functional snRNA genes (like RNU12), which participate in minor spliceosome-mediated splicing of pre-mRNA[3], RNU12-2P lacks protein or catalytic activity and is not implicated as a receptor, enzyme, transporter, or other druggable molecular class. Despite database associations with microcephalic osteodysplastic primordial dwarfism, there is no clear evidence this pseudogene plays a direct pathogenic or therapeutic role; this likely reflects confusion with active snRNA genes such as RNU12. RNU12-2P is not targeted by approved or experimental drugs, and it is not used for biomarker applications or as an efficacy/safety monitoring agent. Context and clarification: - The functional U12 snRNA (RNU12) is part of the minor (U12-dependent) spliceosome and plays a direct role in splicing a small subset of introns[3]. - RNU12-2P is a non-functional, pseudogenic copy and should not be confused with the functional snRNA gene or minor spliceosome components. - There is no evidence supporting RNU12-2P as a drug target, biomarker, or having a role in therapy or disease other than database annotation artifacts[1][6]. If your intent was to find information on the **RNU12 snRNA gene**, which is a bona fide functional target and associated with splicing-related disorders, please clarify, as the entries here reflect only the pseudogene, not the functional component of the spliceosome[1][3][6].

Other names

U12RNU12RNU12PRNA, U12 small nuclear pseudogeneRNU12-2P